 |
 Video: What is a Stock Split?
|
|
|
| CVRx is a commercial-stage medical device company. Co.'s proprietary platform technology, Barostim, is designed to utilize the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure (HF) and other cardiovascular diseases. Co.'s product, Barostim, is commercially available neuromodulation device indicated to improve symptoms for patients with HF with reduced Ejection Fraction. Barostim provides Baroreflex Activation Therapy by sending imperceptible and persistent electrical pulses to baroreceptors located in the wall of the carotid artery to signal the brain to modulate the cardiovascular function. According to our CVRx stock split history records, CVRx has had 0 splits. | |
|
CVRx (CVRX) has 0 splits in our CVRx stock split history database.
Looking at the CVRx stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into CVRx shares, starting with a $10,000 purchase of CVRX, presented on a split-history-adjusted basis factoring in the complete CVRx stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
07/01/2021 |
|
| End date: |
05/03/2024 |
|
| Start price/share: |
$26.07 |
|
| End price/share: |
$9.22 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-64.63% |
|
| Average Annual Total Return: |
-30.64% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$3,536.52 |
|
| Years: |
2.84 |
|
|
|
|
|
